Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Diabetes
•
Cardiology
•
Endocrinology
•
General Endocrinology
Should we recommend SGLT2i initiation at discharge to all patients hospitalized with acute myocardial infarction?
Butler et al., PMID 38587237
Related Questions
Do you use the homeostatic model assessment (HOMA) to assess for insulin resistance and change your clinical management of patients?
How do you adjust your HbA1c goal for managing diabetes in elderly patients with multiple chronic illnesses but no limitations in performing self-care tasks?
Are recurrent UTIs a contraindication to SGLT2i use?
Is ABI (Ankle Brachial index) lower limb arterial doppler not recommended if patient already has arterial stents in the legs, and if so, what other imaging modality would you consider as first-line?
How does the TACTiC trial's success with a web app for statin self-management influence your stance on nonprescription statins for primary prevention amidst statin underuse?
What is your approach to addressing severe dawn phenomenon in your patients with diabetes?
How do you adjust your management strategy to address the unique needs of anuric end-stage kidney disease patients when treating diabetic ketoacidosis?
Will Omnipod 5 work well in patients receiving bursts of corticosteroids or in those on hemodialysis?
Is intermittent fasting effective for weight loss?
Do you recommend continuous glucose monitoring for patients with Type 2 diabetes who are not on insulin?
